Top Tweets for #Sciencewins

Cancer cells just got told to go back to being normal. And they listened. Scientists in South Korea pulled off something that sounds like science fiction. Instead of killing cancer cells (the standard playbook for decades), they flipped them. Reprogrammed them. Sent them home. Researchers at KAIST, led by Professor Kwang-Hyun Cho, built a digital twin of a cancer cell's gene network and went hunting for the exact moment a healthy cell tips over into becoming malignant. That moment has a switch. They found it. By silencing three specific genes (MYB, HDAC2, and FOXA2), the team watched colon cancer cells slow down, lose their aggression, and start behaving like normal intestinal cells again. No gene editing. No toxic chemo. No collateral damage to healthy tissue. Just a quiet rewrite of the cell's fate. They tested it in computer models, in lab dishes, and in mice. The mice given the reprogrammed cells grew far smaller tumors than those left untreated. Traditional cancer treatment is a war. You bomb the bad guys and hope the good ones survive the blast. This is something else entirely. It's reversal. It's persuasion at the cellular level. The study was published in Advanced Science in December 2024, and a follow-up paper in February 2025 captured the molecular switch behind the whole thing. The implications stretch far beyond colon cancer. If cells can be guided home, the entire definition of "treatment" starts to shift. Cancer used to be a sentence. It's starting to look like a question with new answers. Source: KAIST / Advanced Science (Professor Kwang-Hyun Cho et al., 2024–2025)